David J. Waxman

MAnorm2 for quantitatively comparing groups of ChIP-seq samples

Jian Xu, Haojie Chen, Shiqi Tu, 2020, bioRxiv.

Multi‐modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models

David J. Waxman, Catharina de Lange Davies, Steinar Lundgren, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Combination of antiangiogenesis with chemotherapy for more effective cancer treatment

David J. Waxman, D. Waxman, Jie Ma, 2008, Molecular Cancer Therapeutics.

Next generation metronomic chemotherapy—report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6–8 May 2016, Mumbai

Pan Pantziarka, David J. Waxman, Nicolas André, 2016, Ecancermedicalscience.

Down-Regulation of STAT5b Transcriptional Activity by Ligand-Activated Peroxisome Proliferator-Activated Receptor (PPAR) α and PPARγ

David J. Waxman, D. Waxman, Jonathan M. Shipley, 2003 .

Unbiased, Genome-Wide In Vivo Mapping of Transcriptional Regulatory Elements Reveals Sex Differences in Chromatin Structure Associated with Sex-Specific Liver Gene Expression

Ernest Fraenkel, David J. Waxman, Tali Mazor, 2010, Molecular and Cellular Biology.

trans-activation of PPARα and PPARγ by structurally diverse environmental chemicals

David J. Waxman, E. K. Maloney, D. Waxman, 1999 .

trans-Activation of PPARα and Induction of PPARα Target Genes by Perfluorooctane-Based Chemicals

David J. Waxman, D. Waxman, A. Seacat, 2004 .

Genome-Wide Analysis of Chromatin States Reveals Distinct Mechanisms of Sex-Dependent Gene Regulation in Male and Female Mouse Liver

David J. Waxman, D. Waxman, Aarathi Sugathan, 2013, Molecular and Cellular Biology.